CA: A Cancer Journal for Clinicians
@CACancerJournal
Followers
10K
Following
1K
Media
2K
Statuses
5K
As the flagship journal of the American Cancer Society, CA publishes the latest cancer statistics, ACS guidelines, and reviews on the current state of cancer.
Atlanta
Joined January 2009
November marks CA’s 75th anniversary. Published since 1950, CA has grown into the @AmericanCancer flagship journal, publishing trusted, authoritative information about cancer to guide clinicians & researchers worldwide. Read the commemorative editorial: https://t.co/IDjkhFTiMo
0
4
11
New in "Perspectives: Research in Context" 🩺 5 years of FAST-Forward substudy data show no difference in normal tissue effects after 1 week versus 3 weeks of axillary radiotherapy for early breast cancer. Shorter treatment appears safe: https://t.co/tEPvgVhkxC
@OncoAlert
0
2
4
Are you ready to enhance your understanding of cancer cachexia and improve patient outcomes? Join this webinar on November 17th, 2025 at 10:30 AM EST to learn from top clinicians. https://t.co/pWLe7ysRlh
#CancerCare #HealthcareExcellence
0
0
2
#PancreaticCancerAwarenessMonth calls attention to the growing burden of pancreatic cancer and inequities in care. Ensuring inclusive access, early detection, and prevention is key to better outcomes for all communities. 🔗 https://t.co/y5QdA0xMix
@OncoAlert @AmericanCancer
0
2
7
The latest "Perspectives: Research in Context" examines evidence linking frailty to worse cancer treatment outcomes. Geriatric screening tools can help clinicians tailor care and improve outcomes for older adults with cancer: https://t.co/MfFBCKd1V0
@OncoAlert
1
1
7
During #StomachCancerAwarenessMonth, we spotlight disparities: Black patients face higher mortality from stomach & other cancers. Advancing detection, treatment, and equity is critical for better outcomes. Read the full @AmericanCancer report: https://t.co/WRbSqOJP36
@OncoAlert
0
3
6
This #LungCancerAwarenessMonth, we celebrate progress: Nearly 4M lung cancer deaths were prevented in the US from 1970–2022 thanks to effective tobacco control policies. Read the @AmericanCancer study: https://t.co/N4ZRryIVXH
@OncoAlert @AhJemal @FarhadIslami @NigarNargis2
0
9
17
📕 Our November/December issue is here! https://t.co/7zYIXWfepx In this issue: 📌CA’s 75th anniversary 📌Geriatric care in small cell lung cancer 📌2025 prostate cancer stats 📌Germ cell tumors & differences in sex development 📌Reirradiation standards & challenges @OncoAlert
2
2
11
🩺 Pancreatic cancer is rising and often detected late, making it one of the deadliest cancers. For #PancreaticCancerAwarenessMonth, progress in screening, treatment, and research underscores the need for equitable, innovative care: https://t.co/1rhdJHt87n
@OncoAlert
1
22
39
Submit your phase 3 trials to CA for rapid review and publication! As the highest ranking impact factor journal among oncology titles, CA aims to provide study teams access to as broad a readership as possible without restrictive pay walls. More info: https://t.co/AZWKY4hjbO
0
0
0
The flagship journal of the @AmericanCancer Society - @CACancerJournal - celebrates its 75th year in continuous publication! 🎉👏 Read the commemorative editorial about the journal here: https://t.co/8C0sgWmR9A
0
1
1
🫁 In honor of #LungCancerAwarenessMonth, take a moment to revisit the @AmericanCancer 2023 #LungCancer screening guideline. This update removed the “years since quitting” restriction, expanding access to early detection. 🔗: https://t.co/zcJSEAUfiV
@ACSNews @OncoAlert
1
8
24
November is #NativeAmericanHeritageMonth Did you know that Native American men have 12% higher prostate cancer mortality than White men despite 13% lower incidence? Learn more in this #ProstateCancerStatistics report from @CACancerJournal: https://t.co/b5i2yMU5WL
@ACS_Research
0
1
2
Mutations in the tyrosine kinase domain of EGFR represent one of the most common druggable alterations in #NSCLC. This recent review provides a comprehensive clinical overview of the management of patients with EGFR-mutant NSCLC. https://t.co/DsurY1HqxY
@OncoAlert @Alfdoc2
2
18
73
We are thrilled to announce @KekoaMDPhD as a new Associate Editor. Dr. Taparra is a Tenure-Track Assistant Professor @UCLAFSPH and @dgsomucla w/ research interests in bridging molecular and clinical research with population-level data to improve cancer care access. Welcome!
1
2
7
Best practices for clinician communication with #AYA cancer survivors? 🙏 Maintain openness and compassion 🌱 Be flexible and adaptive to evolving needs Read more from @AbbyRosenbergMD @LCHeathcote @l_schapira et al: https://t.co/bjgjHHqa0g
@OncoAlert #AYACSM
1
4
8
Revisit this #VirtualTumorBoard from @BrownMedicine researchers covering a complex case of newly diagnosed breast cancer with TP53 PV/LPV. Explore insights from the multidisciplinary panel and the patient's perspective: https://t.co/UbOirZtXUs
@OncoAlert #TumorBoardTuesday
0
5
9
A recent @AmericanCancer report underscores the need for redoubled efforts to optimize early detection while limiting #ProstateCancer overdiagnosis and to address barriers to equitable outcomes, particularly for Native American men. https://t.co/wSc82rgOaW
@OncoAlert
0
2
7
The 2024 #BreastCancer statistics report from @AmericanCancer sheds light on trends among AAPI women, including a significant rise in incidence rates over the past two decades. See more stats in the #OpenAccess publication: https://t.co/cgrtut0RIt
@OncoAlert #BCSM
0
2
7
Don’t miss the Breast Cancer Research Virtual Issue from the @AmericanCancer journals! It features our recently published case highlighting how genetic testing and multidisciplinary care guide treatment in young patients. 👉 https://t.co/o69Ih4OIXn
#BCAM @OncoAlert
0
6
6